s6y Ayala Pharmaceuticals, Inc. 10-Q

Ayala Pharmaceuticals, Inc. 10-Q, filed Mar 10, 2017: IDEA: XBRL DOCUMENT

Fair Value - Schedule of Common Stock Warrant Liability (Details)
3 Months Ended
Jan. 31, 2017
USD ($)
Fair Value Disclosures [Abstract]  
Beginning balance $ 20,156
Change in fair value (9,504)
Ending balance $ 10,652